Researchers at the Daffodil Centre are Chief Investigators on three pivotal National Health and Medical Research Council (NHMRC) Centre’s of Research Excellence (CRE) in the most recent funding announcement.
Genetic Epidemiology for Precision Population Health
Associate Professor Julia Steinberg is a Chief Investigator for the CRE in Genetic Epidemiology for Precision Population Health.
Led by Dr Shuai Li at the University of Melbourne’s School of Population and Global Health, this CRE will utilise their expertise to study how genes and environment combined to influence disease, the causes of diseases and how to better predict disease risk. We will transfer our findings to health policy and practice, and build Australia’s capacity in the interdisciplinary field of genetic epidemiology and population health to transform Australia into a worldwide leader in precision population health. Read more about the CRE in Genetic Epidemiology for Precision Population Health funding announcement.
Women’s Sexual and Reproductive Health in Primary Care (SPHERE)
Professor Deborah Bateson AM is a Chief Investigator for the CRE in Women’s Sexual and Reproductive Health in Primary Care (SPHERE).
Led by Professor Danielle Mazza AM from the Monash University’s School of Public Health and Preventive Medicine, SPHERE 2.0 aims to increase access to high-quality, patient-centred sexual and reproductive health care so that women in Australia can achieve bodily autonomy and have the number of children they want when they want them. Read more about the SPHERE funding announcement.
Visit spherecre.org for more information on what they have achieved to date.
Stronger Investments for Infectious Diseases (STRIDE)
Professor Karen Canfell is a Chief Investigator for the CRE in Stronger Investments for Infectious Diseases (STRIDE).
Led by Professor Virginia Wiseman from the Kirby Institute at UNSW, STRIDE will be Australia’s first dynamic hub for applied and policy-relevant research on the economics of infectious disease interventions. STRIDE will provide the framework, enhanced capacity among researchers and policymakers, and robust evidence needed to comprehensively assess the full impacts of infectious disease interventions, placing Australia and countries in the region in a stronger position to optimise substantial future investments in pandemic preparedness at a national level. Read more about the STRIDE funding announcement.
A complete list of projects supported by the NHMRC’s 2023 CRE scheme is available on the NHMRC website.
